Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Admission diagnoses of patients later diagnosed with autoimmune encephalitis.

Baumgartner A, Rauer S, Hottenrott T, Leypoldt F, Ufer F, Hegen H, Prüss H, Lewerenz J, Deisenhammer F, Stich O.

J Neurol. 2018 Nov 12. doi: 10.1007/s00415-018-9105-3. [Epub ahead of print]

PMID:
30421340
2.

The prevalence of neural antibodies in temporal lobe epilepsy and the clinical characteristics of seropositive patients.

Elisak M, Krysl D, Hanzalova J, Volna K, Bien CG, Leypoldt F, Marusic P.

Seizure. 2018 Sep 17;63:1-6. doi: 10.1016/j.seizure.2018.09.009. [Epub ahead of print]

PMID:
30391660
3.

Autoantibody-Mediated Encephalitis.

Wandinger KP, Leypoldt F, Junker R.

Dtsch Arztebl Int. 2018 Nov 5;115(40):666-673. doi: 10.3238/arztebl.2018.0666.

4.

Sex differences in autoimmune disorders of the central nervous system.

Gold SM, Willing A, Leypoldt F, Paul F, Friese MA.

Semin Immunopathol. 2018 Oct 25. doi: 10.1007/s00281-018-0723-8. [Epub ahead of print]

PMID:
30361800
5.

Biomarkers of Neurodegeneration in Autoimmune-Mediated Encephalitis.

Körtvelyessy P, Prüss H, Thurner L, Maetzler W, Vittore-Welliong D, Schultze-Amberger J, Heinze HJ, Reinhold D, Leypoldt F, Schreiber S, Bittner D.

Front Neurol. 2018 Sep 19;9:668. doi: 10.3389/fneur.2018.00668. eCollection 2018.

6.

A Klinefelter patient with an additional mitochondrial mutation: Implications for genotype-driven treatment and mitochondrial mutational load in different tissues and family members.

Dulovic M, Schäffer E, Leypoldt F, Balck A, Schaake S, Hinrichs F, Kirchner H, Brüggemann N, Berg D, Lohmann K.

Parkinsonism Relat Disord. 2018 Sep;54:116-118. doi: 10.1016/j.parkreldis.2018.04.001. Epub 2018 Apr 3. No abstract available.

PMID:
29650490
7.

Genetic predisposition in anti-LGI1 and anti-NMDA receptor encephalitis.

Mueller SH, Färber A, Prüss H, Melzer N, Golombeck KS, Kümpfel T, Thaler F, Elisak M, Lewerenz J, Kaufmann M, Sühs KW, Ringelstein M, Kellinghaus C, Bien CG, Kraft A, Zettl UK, Ehrlich S, Handreka R, Rostásy K, Then Bergh F, Faiss JH, Lieb W, Franke A, Kuhlenbäumer G, Wandinger KP, Leypoldt F; German Network for Research on Autoimmune Encephalitis (GENERATE).

Ann Neurol. 2018 Apr;83(4):863-869. doi: 10.1002/ana.25216.

PMID:
29572931
8.

MOG-IgG in primary and secondary chronic progressive multiple sclerosis: a multicenter study of 200 patients and review of the literature.

Jarius S, Ruprecht K, Stellmann JP, Huss A, Ayzenberg I, Willing A, Trebst C, Pawlitzki M, Abdelhak A, Grüter T, Leypoldt F, Haas J, Kleiter I, Tumani H, Fechner K, Reindl M, Paul F, Wildemann B.

J Neuroinflammation. 2018 Mar 19;15(1):88. doi: 10.1186/s12974-018-1108-6.

9.

NMDAR encephalitis: passive transfer from man to mouse by a recombinant antibody.

Malviya M, Barman S, Golombeck KS, Planagumà J, Mannara F, Strutz-Seebohm N, Wrzos C, Demir F, Baksmeier C, Steckel J, Falk KK, Gross CC, Kovac S, Bönte K, Johnen A, Wandinger KP, Martín-García E, Becker AJ, Elger CE, Klöcker N, Wiendl H, Meuth SG, Hartung HP, Seebohm G, Leypoldt F, Maldonado R, Stadelmann C, Dalmau J, Melzer N, Goebels N.

Ann Clin Transl Neurol. 2017 Oct 3;4(11):768-783. doi: 10.1002/acn3.444. eCollection 2017 Nov.

10.

Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome.

Hennes EM, Baumann M, Schanda K, Anlar B, Bajer-Kornek B, Blaschek A, Brantner-Inthaler S, Diepold K, Eisenkölbl A, Gotwald T, Kuchukhidze G, Gruber-Sedlmayr U, Häusler M, Höftberger R, Karenfort M, Klein A, Koch J, Kraus V, Lechner C, Leiz S, Leypoldt F, Mader S, Marquard K, Poggenburg I, Pohl D, Pritsch M, Raucherzauner M, Schimmel M, Thiels C, Tibussek D, Vieker S, Zeches C, Berger T, Reindl M, Rostásy K; BIOMARKER Study Group.

Neurology. 2017 Aug 29;89(9):900-908. doi: 10.1212/WNL.0000000000004312. Epub 2017 Aug 2.

11.

Mechanisms of Autoantibody-Induced Pathology.

Ludwig RJ, Vanhoorelbeke K, Leypoldt F, Kaya Z, Bieber K, McLachlan SM, Komorowski L, Luo J, Cabral-Marques O, Hammers CM, Lindstrom JM, Lamprecht P, Fischer A, Riemekasten G, Tersteeg C, Sondermann P, Rapoport B, Wandinger KP, Probst C, El Beidaq A, Schmidt E, Verkman A, Manz RA, Nimmerjahn F.

Front Immunol. 2017 May 31;8:603. doi: 10.3389/fimmu.2017.00603. eCollection 2017. Review.

12.

ADEM-like presentation, anti-MOG antibodies, and MS pathology: TWO case reports.

Körtvélyessy P, Breu M, Pawlitzki M, Metz I, Heinze HJ, Matzke M, Mawrin C, Rommer P, Kovacs GG, Mitter C, Reindl M, Brück W, Wandinger KP, Lassmann H, Höftberger R, Leypoldt F.

Neurol Neuroimmunol Neuroinflamm. 2017 Mar 14;4(3):e335. doi: 10.1212/NXI.0000000000000335. eCollection 2017 May. No abstract available.

13.

Apolipoproteins and their subspecies in human cerebrospinal fluid and plasma.

Koch M, Furtado JD, Falk K, Leypoldt F, Mukamal KJ, Jensen MK.

Alzheimers Dement (Amst). 2017 Feb 24;6:182-187. doi: 10.1016/j.dadm.2017.01.007. eCollection 2017.

14.

Serum neuronal cell-surface antibodies in first-episode psychosis.

Leypoldt F, de Witte L, Lancaster E, Titulaer MJ.

Lancet Psychiatry. 2017 Mar;4(3):186-187. doi: 10.1016/S2215-0366(17)30043-3. No abstract available.

PMID:
28236946
15.

[Autoantibody-associated autoimmune encephalitis and cerebellitis : Clinical presentation, diagnostic work-up and treatment].

Lewerenz J, Jarius S, Wildemann B, Wandinger KP, Leypoldt F.

Nervenarzt. 2016 Dec;87(12):1293-1299. Review. German.

PMID:
27847964
16.

Orthostatic myoclonus associated with Caspr2 antibodies.

van Gerpen JA, Ahlskog JE, Chen R, Fung VS, Hallett M, Gövert F, Deuschl G, Leypoldt F.

Neurology. 2016 Sep 13;87(11):1187-8. doi: 10.1212/WNL.0000000000003140. No abstract available.

PMID:
27621382
17.

The clinical spectrum of Caspr2 antibody-associated disease.

van Sonderen A, Ariño H, Petit-Pedrol M, Leypoldt F, Körtvélyessy P, Wandinger KP, Lancaster E, Wirtz PW, Schreurs MW, Sillevis Smitt PA, Graus F, Dalmau J, Titulaer MJ.

Neurology. 2016 Aug 2;87(5):521-8. doi: 10.1212/WNL.0000000000002917. Epub 2016 Jul 1.

18.

Orthostatic myoclonus associated with Caspr2 antibodies.

Gövert F, Witt K, Erro R, Hellriegel H, Paschen S, Martinez-Hernandez E, Wandinger KP, Deuschl G, Dalmau J, Leypoldt F.

Neurology. 2016 Apr 5;86(14):1353-5. doi: 10.1212/WNL.0000000000002547. Epub 2016 Mar 4. No abstract available.

19.

A clinical approach to diagnosis of autoimmune encephalitis.

Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, Cortese I, Dale RC, Gelfand JM, Geschwind M, Glaser CA, Honnorat J, Höftberger R, Iizuka T, Irani SR, Lancaster E, Leypoldt F, Prüss H, Rae-Grant A, Reindl M, Rosenfeld MR, Rostásy K, Saiz A, Venkatesan A, Vincent A, Wandinger KP, Waters P, Dalmau J.

Lancet Neurol. 2016 Apr;15(4):391-404. doi: 10.1016/S1474-4422(15)00401-9. Epub 2016 Feb 20. Review.

20.

Quantitative T2* mapping reveals early temporo-spatial dynamics in an ischemic stroke model.

Gersing AS, Faymonville AM, Schwaiger BJ, Leypoldt F, Siemonsen S, Zimmer C, Magnus T, Fiehler J.

J Neurosci Methods. 2016 Feb 1;259:83-89. doi: 10.1016/j.jneumeth.2015.11.018. Epub 2015 Nov 29.

PMID:
26645798
21.

Antibodies to MOG and AQP4 in children with neuromyelitis optica and limited forms of the disease.

Lechner C, Baumann M, Hennes EM, Schanda K, Marquard K, Karenfort M, Leiz S, Pohl D, Venkateswaran S, Pritsch M, Koch J, Schimmel M, Häusler M, Klein A, Blaschek A, Thiels C, Lücke T, Gruber-Sedlmayr U, Kornek B, Hahn A, Leypoldt F, Sandrieser T, Gallwitz H, Stoffels J, Korenke C, Reindl M, Rostásy K.

J Neurol Neurosurg Psychiatry. 2016 Aug;87(8):897-905. doi: 10.1136/jnnp-2015-311743. Epub 2015 Dec 8.

PMID:
26645082
22.

Gardening gone awry: Aberrant spine pruning disrupts long-range networks.

Leypoldt F, Münchau A.

Mov Disord. 2015 Oct;30(12):1621. doi: 10.1002/mds.26380. Epub 2015 Aug 21. Review. No abstract available.

PMID:
26293311
23.

Progressive neurologic dysfunction in a psoriasis patient treated with dimethyl fumarate.

Bartsch T, Rempe T, Wrede A, Leypoldt F, Brück W, Adams O, Rohr A, Jansen O, Wüthrich C, Deuschl G, Koralnik IJ.

Ann Neurol. 2015 Oct;78(4):501-14. doi: 10.1002/ana.24471. Epub 2015 Jul 31. Review.

24.

Encephalitis and AMPA receptor antibodies: Novel findings in a case series of 22 patients.

Höftberger R, van Sonderen A, Leypoldt F, Houghton D, Geschwind M, Gelfand J, Paredes M, Sabater L, Saiz A, Titulaer MJ, Graus F, Dalmau J.

Neurology. 2015 Jun 16;84(24):2403-12. doi: 10.1212/WNL.0000000000001682. Epub 2015 May 15.

25.

Structural Hippocampal Damage Following Anti-N-Methyl-D-Aspartate Receptor Encephalitis.

Finke C, Kopp UA, Pajkert A, Behrens JR, Leypoldt F, Wuerfel JT, Ploner CJ, Prüss H, Paul F.

Biol Psychiatry. 2016 May 1;79(9):727-34. doi: 10.1016/j.biopsych.2015.02.024. Epub 2015 Feb 26.

PMID:
25866294
26.

Investigations on CXCL13 in anti-N-methyl-D-aspartate receptor encephalitis: a potential biomarker of treatment response.

Leypoldt F, Höftberger R, Titulaer MJ, Armangue T, Gresa-Arribas N, Jahn H, Rostásy K, Schlumberger W, Meyer T, Wandinger KP, Rosenfeld MR, Graus F, Dalmau J.

JAMA Neurol. 2015 Feb;72(2):180-6. doi: 10.1001/jamaneurol.2014.2956.

27.

Human N-methyl D-aspartate receptor antibodies alter memory and behaviour in mice.

Planagumà J, Leypoldt F, Mannara F, Gutiérrez-Cuesta J, Martín-García E, Aguilar E, Titulaer MJ, Petit-Pedrol M, Jain A, Balice-Gordon R, Lakadamyali M, Graus F, Maldonado R, Dalmau J.

Brain. 2015 Jan;138(Pt 1):94-109. doi: 10.1093/brain/awu310. Epub 2014 Nov 11.

28.

Autoimmune encephalopathies.

Leypoldt F, Armangue T, Dalmau J.

Ann N Y Acad Sci. 2015 Mar;1338:94-114. doi: 10.1111/nyas.12553. Epub 2014 Oct 14. Review.

29.

Immunoglobulin G antibodies to the N-Methyl-D-aspartate receptor are distinct from immunoglobulin A and immunoglobulin M responses.

Lancaster E, Leypoldt F, Titulaer MJ, Honnorat J, Waters PJ, Reindl M, Höftberger R.

Ann Neurol. 2015 Jan;77(1):183. doi: 10.1002/ana.24233. Epub 2014 Dec 4. No abstract available.

30.

Author response.

Leypoldt F, Dalmau J.

Neurology. 2014 Jun 3;82(22):2041. No abstract available.

PMID:
25013887
31.

Autoimmune encephalitis as differential diagnosis of infectious encephalitis.

Armangue T, Leypoldt F, Dalmau J.

Curr Opin Neurol. 2014 Jun;27(3):361-8. doi: 10.1097/WCO.0000000000000087. Review.

32.

Overlapping demyelinating syndromes and anti–N-methyl-D-aspartate receptor encephalitis.

Titulaer MJ, Höftberger R, Iizuka T, Leypoldt F, McCracken L, Cellucci T, Benson LA, Shu H, Irioka T, Hirano M, Singh G, Cobo Calvo A, Kaida K, Morales PS, Wirtz PW, Yamamoto T, Reindl M, Rosenfeld MR, Graus F, Saiz A, Dalmau J.

Ann Neurol. 2014 Mar;75(3):411-28.

33.

Antibodies to N-methyl-D-aspartate and other synaptic receptors in choreoathetosis and relapsing symptoms post-herpes virus encephalitis.

Titulaer MJ, Leypoldt F, Dalmau J.

Mov Disord. 2014 Jan;29(1):3-6. doi: 10.1002/mds.25716. Epub 2013 Nov 4. No abstract available.

34.

Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study.

Gresa-Arribas N, Titulaer MJ, Torrents A, Aguilar E, McCracken L, Leypoldt F, Gleichman AJ, Balice-Gordon R, Rosenfeld MR, Lynch D, Graus F, Dalmau J.

Lancet Neurol. 2014 Feb;13(2):167-77. doi: 10.1016/S1474-4422(13)70282-5. Epub 2013 Dec 18. Erratum in: Lancet Neurol. 2014 Feb;13(2):135.

35.

Herpes simplex virus encephalitis is a trigger of brain autoimmunity.

Armangue T, Leypoldt F, Málaga I, Raspall-Chaure M, Marti I, Nichter C, Pugh J, Vicente-Rasoamalala M, Lafuente-Hidalgo M, Macaya A, Ke M, Titulaer MJ, Höftberger R, Sheriff H, Glaser C, Dalmau J.

Ann Neurol. 2014 Feb;75(2):317-23. doi: 10.1002/ana.24083. Epub 2014 Feb 25.

36.

Herpes simplex virus-1 encephalitis can trigger anti-NMDA receptor encephalitis: case report.

Leypoldt F, Titulaer MJ, Aguilar E, Walther J, Bönstrup M, Havemeister S, Teegen B, Lütgehetmann M, Rosenkranz M, Magnus T, Dalmau J.

Neurology. 2013 Oct 29;81(18):1637-9. doi: 10.1212/WNL.0b013e3182a9f531. Epub 2013 Oct 2. No abstract available.

37.

Immune activation in amyloid-β-related angiitis correlates with decreased parenchymal amyloid-β plaque load.

Bogner S, Bernreuther C, Matschke J, Barrera-Ocampo A, Sepulveda-Falla D, Leypoldt F, Magnus T, Haag F, Bergmann M, Brück W, Vogelgesang S, Glatzel M.

Neurodegener Dis. 2014;13(1):38-44. doi: 10.1159/000352020. Epub 2013 Sep 6.

PMID:
24021982
38.

[Autoimmune encephalitis].

Leypoldt F.

Fortschr Neurol Psychiatr. 2013 Sep;81(9):523-37; quiz 538. doi: 10.1055/s-0033-1350145. Epub 2013 Aug 28. Review. German. No abstract available.

PMID:
23986460
39.

Paraneoplastic neurological syndromes.

Leypoldt F, Wandinger KP.

Clin Exp Immunol. 2014 Mar;175(3):336-48. doi: 10.1111/cei.12185. Review.

40.

Autoimmune Encephalitis.

Leypoldt F, Wandinger KP, Bien CG, Dalmau J.

Eur Neurol Rev. 2013 Summer;8(1):31-37.

41.
42.

Functional and structural brain changes in anti-N-methyl-D-aspartate receptor encephalitis.

Finke C, Kopp UA, Scheel M, Pech LM, Soemmer C, Schlichting J, Leypoldt F, Brandt AU, Wuerfel J, Probst C, Ploner CJ, Prüss H, Paul F.

Ann Neurol. 2013 Aug;74(2):284-96. doi: 10.1002/ana.23932. Epub 2013 Jul 8.

PMID:
23686722
43.

Recovery from severe frontotemporal dysfunction at 3years after N-methyl-d-aspartic acid (NMDA) receptor antibody encephalitis.

Leypoldt F, Gelderblom M, Schöttle D, Hoffmann S, Wandinger KP.

J Clin Neurosci. 2013 Apr;20(4):611-3. doi: 10.1016/j.jocn.2012.03.036. Epub 2013 Jan 11.

PMID:
23313527
44.

A clinical and neurobiological case of IgM NMDA receptor antibody associated encephalitis mimicking bipolar disorder.

Choe CU, Karamatskos E, Schattling B, Leypoldt F, Liuzzi G, Gerloff C, Friese MA, Mulert C.

Psychiatry Res. 2013 Jul 30;208(2):194-6. doi: 10.1016/j.psychres.2012.09.035. Epub 2012 Dec 13.

PMID:
23246244
45.

Neutralization of the IL-17 axis diminishes neutrophil invasion and protects from ischemic stroke.

Gelderblom M, Weymar A, Bernreuther C, Velden J, Arunachalam P, Steinbach K, Orthey E, Arumugam TV, Leypoldt F, Simova O, Thom V, Friese MA, Prinz I, Hölscher C, Glatzel M, Korn T, Gerloff C, Tolosa E, Magnus T.

Blood. 2012 Nov 1;120(18):3793-802. doi: 10.1182/blood-2012-02-412726. Epub 2012 Sep 13.

46.

Fluorodeoxyglucose positron emission tomography in anti-N-methyl-D-aspartate receptor encephalitis: distinct pattern of disease.

Leypoldt F, Buchert R, Kleiter I, Marienhagen J, Gelderblom M, Magnus T, Dalmau J, Gerloff C, Lewerenz J.

J Neurol Neurosurg Psychiatry. 2012 Jul;83(7):681-6. doi: 10.1136/jnnp-2011-301969. Epub 2012 May 7.

47.

The flavonoid fisetin attenuates postischemic immune cell infiltration, activation and infarct size after transient cerebral middle artery occlusion in mice.

Gelderblom M, Leypoldt F, Lewerenz J, Birkenmayer G, Orozco D, Ludewig P, Thundyil J, Arumugam TV, Gerloff C, Tolosa E, Maher P, Magnus T.

J Cereb Blood Flow Metab. 2012 May;32(5):835-43. doi: 10.1038/jcbfm.2011.189. Epub 2012 Jan 11.

48.

Ataxia and HIV: clinicopathologic correlations in a case of HIV-associated cerebellar leukoencephalopathy.

Ganos C, Bernreuther C, Matschke J, Gerloff C, Münchau A, Leypoldt F.

Cerebellum. 2012 Sep;11(3):816-9. doi: 10.1007/s12311-011-0345-3. No abstract available.

PMID:
22205440
49.

Symptomatic paroxysmal kinesigenic choreoathetosis as primary manifestation of multiple sclerosis.

Zittel S, Bester M, Gerloff C, Münchau A, Leypoldt F.

J Neurol. 2012 Mar;259(3):557-8. doi: 10.1007/s00415-011-6188-5. Epub 2011 Jul 30. No abstract available.

PMID:
21805257
50.

CD38 exacerbates focal cytokine production, postischemic inflammation and brain injury after focal cerebral ischemia.

Choe CU, Lardong K, Gelderblom M, Ludewig P, Leypoldt F, Koch-Nolte F, Gerloff C, Magnus T.

PLoS One. 2011;6(5):e19046. doi: 10.1371/journal.pone.0019046. Epub 2011 May 13. Erratum in: PLoS One. 2011;6(7). doi:10.1371/annotation/295c388d-013d-4bb9-b4e4-da8e88317594.

Supplemental Content

Loading ...
Support Center